SMER28 是一种自噬小分子增强剂，通过不依赖于 mTOR 的机制诱导哺乳动物细胞中独立于雷帕霉素的自噬，并阻止淀粉样蛋白 β 肽的积累。

SMER28 is a small-molecule enhancer (SMER) of autophagy, inducing autophagy independently of rapamycin in mammalian cells via an mTOR-independent mechanism and prevented the accumulation of amyloid beta peptide.

SMER28 is a positive regulator of autophagy in a mechanism independent from the mTOR pathway. It increases autophagosome synthesis and enhances the clearance of model autophagy substrates such as A53T a-synuclein and mutant huntingtin fragments. A marked decrease in Aβ/APP-CTF levels and enhancement for degradation of Aβ/APP-CTF via autophagy is also induced by SMER28. APP-CTF and LC3-II are cocompartmentalized on SMER28 treatment[1].

MEF cells overexpressing βCTF are treated with autophagy-enhancing compounds (10 μM) for 16 h. Cell lysates are analyzed by SDS-PAGE and Western blotting using anti-βCTF (6E10) and anti-tubulin antibodies.(Only for Reference)

307538-42-7

C11H10BrN3

264.12

DMSO:26.4 mg/mL (100 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years